Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells

Cancer Letters

Volumn 261, Issue 1, 2008, Pages 37-45

  Choi, Bo Hwa ^a   Kim, Wanil ^c   Wang, Qiuxia Chelsia ^a   Kim, Dong Chan ^c   Tan, Swee Ngin ^b   Yong, Jean Wan Hong ^b   Kim, Kyong Tai ^c   Yoon, Ho Sup ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Apoptosis; Bcl 2; Cancer; Caspase 3; Kinetin riboside

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYTOCHROME C; DACARBAZINE; KINETIN RIBOSIDE; PROTEIN BCL XL; PROTEIN BNIP3; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL FRACTIONATION; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME REGULATION; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOSINE; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 3; CATTLE; CELL LINE; CELL LINE, TUMOR; CYTOCHROMES C; FIBROBLASTS; HUMANS; KINETIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

BOVINAE; MUS;

EID: 38949162240     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.014     Document Type: Article

References (30)

1. Amasino R. 1955: kinetin arrives: the 50th anniversary of a new plant hormone. Plant Physiol. 138 (2005) 1171-1184
2. Barciszewski J., Massino F., and Clark B.F. Kinetin - a multiactive molecule. Int. J. Biol. Macromol. 40 (2007) 182-192
3. Barciszewski J., Siboska G.E., Pedersen B.O., Clark B.F., and Rattan S.I.S. Evidence for the presence of kinetin in DNA and cell extracts. FEBS lett. 393 (1996) 197-200
4. Ge L., Yong J.W., Goh N.K., Chia L.S., Tan S.N., and Ong E.S. Identification of kinetin and kinetin riboside in coconut (Cocos nucifera L.) water using a combined approach of liquid chromatography-tandem mass spectrometry, high performance liquid chromatography and capillary electrophoresis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 829 (2005) 26-34
5. Sharma S.P., Kaur J., and Rattan S.I.S. Plant growth hormone kinetin delays ageing, prolongs the lifespan and slows down development of the fruitfly Zaprionus paravittiger. Biochem. Biophys. Res. Commun. 216 (1995) 1067-1071
6. Sharma S.P., Kaur J., and Rattan S.I.S. Increased longevity of kinetin-fed Zaprionus fruitflies is accompanied by their reduced fecundity and enhanced catalase activity. Biochem. Mol. Biol. Int. 41 (1997) 869-875
7. Ishii Y., Hori Y., Sakai S., and Honma Y. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones. Cell Growth Differ. 13 (2002) 19-26
8. Griffaut B., Bos R., Maurizis J.C., Madelmont J.C., and Ledoigt G. Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells. Int. J. Biol. Macromol. 34 (2004) 271-275
9. Cory S., and Adams J.M. The Bcl-2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2 (2002) 647-656
10. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
11. Baliga B.C., and Kumar S. Role of Bcl-2 family of proteins in malignancy. Hematol. Oncol. 20 (2002) 63-74
12. Raff M.C., Whitmore A.V., and Finn J.T. Axonal self-destruction and neurodegeneration. Science 296 (2002) 868-871
13. Amundson S.A., Myers T.G., Scudiero D., Kitada S., Reed J.C., and Fornace A.J. An informatic approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60 (2000) 6101-6110
14. Jansen B., Wacheck V., Heere-Ress E., Schlagbauer-Wad1 H., Hoeller C., Lucas T., et al. Chemosensitization of malignant melanoma by Bcl-2 antisense therapy. Lancet 356 (2000) 1728-1733
15. Waters J.S., Webb A., Cunningham D., Clarke P.A., Raynaud F., di Stefano F., et al. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J. Clin. Oncol. 18 (2000) 1812-1823
16. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
17. Wang I.L., Liu D., Zhang Z.J., Shan S., Han X., Srinivasula S.M., et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl. Acad. Sci. USA 97 (2000) 7124-7129
18. Park Y.S., Hur E.M., Choi B.H., Kwak E., Jun D.J., Park S.J., et al. Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dence-core vesicle (LDCV) exocytosis in chromaffin cells. J. Neurosci. 26 (2006) 8999-9005
19. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
20. Shirane M., and Nakayama K.I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nature Cell Biol. 5 (2003) 1-10
21. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J.L., Petit P.X., et al. Reduction of mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181 (1995) 1661-1672
22. Von Ahsen O., Waterhouse N.J., Kuwana T., Newmeyer D.D., and Green D.R. The 'harmless' release of cytochrome c. Cell Death Differ. 7 (2000) 1192-1199
23. Grossman D., and Altieri D.C. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev. 20 (2001) 3-11
24. Fleischer A., Ghadiri A., Dessauge F., Duhamel M., Rebollo M.P., Alvarez-Franco F., et al. Modulating apoptosis as a target for effective therapy. Mol. Immunol. 43 (2006) 1065-1079
25. Kaufmann S.H., and Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256 (2000) 42-49
26. Preston T.J., Abadi A., Wilson L., and Singh G. Mitochondrial contributions to cancer cell physiology: potential for drug development. Adv. Drug Deliv. Rev. 49 (2001) 45-61
27. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
28. Serrone L., Zeuli M., Sega F.M., and Cognetti F. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J. Exp. Clin. Cancer Res. 19 (2000) 21-34
29. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17 (1998) 1675-1687
30. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 310 (2005) 66-67